Lymphatic filariasis in Nigeria; micro-stratification overlap mapping (MOM) as a prerequisite for cost-effective resource utilization in control and surveillance.
Identifieur interne : 001A47 ( PubMed/Checkpoint ); précédent : 001A46; suivant : 001A48Lymphatic filariasis in Nigeria; micro-stratification overlap mapping (MOM) as a prerequisite for cost-effective resource utilization in control and surveillance.
Auteurs : Patricia N. Okorie [Nigeria] ; George O. Ademowo ; Yisa Saka ; Emmanuel Davies ; Chukwu Okoronkwo ; Moses J. Bockarie ; David H. Molyneux ; Louise A. Kelly-HopeSource :
- PLoS neglected tropical diseases [ 1935-2735 ] ; 2013.
Descripteurs français
- KwdFr :
- MESH :
- isolement et purification : Wuchereria bancrofti.
- traitement médicamenteux : Filariose lymphatique.
- épidémiologie : Filariose lymphatique, Nigeria.
- Animaux, Filariose lymphatique, Humains, Prévalence, Topographie médicale, Épidémiosurveillance.
- Wicri :
- geographic : Nigeria.
English descriptors
- KwdEn :
- MESH :
- geographic , epidemiology : Nigeria.
- drug therapy : Elephantiasis, Filarial.
- epidemiology : Elephantiasis, Filarial.
- isolation & purification : Wuchereria bancrofti.
- prevention & control : Elephantiasis, Filarial.
- Animals, Epidemiological Monitoring, Humans, Prevalence, Topography, Medical.
Abstract
Nigeria has a significant burden of lymphatic filariasis (LF) caused by the parasite Wuchereria bancrofti. A major concern to the expansion of the LF elimination programme is the risk of serious adverse events (SAEs) associated with the use of ivermectin in areas co-endemic with Loa filariasis. To better understand this, as well as other factors that may impact on LF elimination, we used Micro-stratification Overlap Mapping (MOM) to highlight the distribution and potential impact of multiple disease interventions that geographically coincide in LF endemic areas and which will impact on LF and vice versa.
DOI: 10.1371/journal.pntd.0002416
PubMed: 24040432
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:24040432Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Lymphatic filariasis in Nigeria; micro-stratification overlap mapping (MOM) as a prerequisite for cost-effective resource utilization in control and surveillance.</title><author><name sortKey="Okorie, Patricia N" sort="Okorie, Patricia N" uniqKey="Okorie P" first="Patricia N" last="Okorie">Patricia N. Okorie</name><affiliation wicri:level="4"><nlm:affiliation>Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Nigeria.</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan</wicri:regionArea><orgName type="university">Université d'Ibadan</orgName><placeName><settlement type="city">Ibadan</settlement><region type="region">État d'Oyo</region></placeName></affiliation></author><author><name sortKey="Ademowo, George O" sort="Ademowo, George O" uniqKey="Ademowo G" first="George O" last="Ademowo">George O. Ademowo</name></author><author><name sortKey="Saka, Yisa" sort="Saka, Yisa" uniqKey="Saka Y" first="Yisa" last="Saka">Yisa Saka</name></author><author><name sortKey="Davies, Emmanuel" sort="Davies, Emmanuel" uniqKey="Davies E" first="Emmanuel" last="Davies">Emmanuel Davies</name></author><author><name sortKey="Okoronkwo, Chukwu" sort="Okoronkwo, Chukwu" uniqKey="Okoronkwo C" first="Chukwu" last="Okoronkwo">Chukwu Okoronkwo</name></author><author><name sortKey="Bockarie, Moses J" sort="Bockarie, Moses J" uniqKey="Bockarie M" first="Moses J" last="Bockarie">Moses J. Bockarie</name></author><author><name sortKey="Molyneux, David H" sort="Molyneux, David H" uniqKey="Molyneux D" first="David H" last="Molyneux">David H. Molyneux</name></author><author><name sortKey="Kelly Hope, Louise A" sort="Kelly Hope, Louise A" uniqKey="Kelly Hope L" first="Louise A" last="Kelly-Hope">Louise A. Kelly-Hope</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:24040432</idno><idno type="pmid">24040432</idno><idno type="doi">10.1371/journal.pntd.0002416</idno><idno type="wicri:Area/PubMed/Corpus">001922</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001922</idno><idno type="wicri:Area/PubMed/Curation">001922</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001922</idno><idno type="wicri:Area/PubMed/Checkpoint">001922</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001922</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Lymphatic filariasis in Nigeria; micro-stratification overlap mapping (MOM) as a prerequisite for cost-effective resource utilization in control and surveillance.</title><author><name sortKey="Okorie, Patricia N" sort="Okorie, Patricia N" uniqKey="Okorie P" first="Patricia N" last="Okorie">Patricia N. Okorie</name><affiliation wicri:level="4"><nlm:affiliation>Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Nigeria.</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan</wicri:regionArea><orgName type="university">Université d'Ibadan</orgName><placeName><settlement type="city">Ibadan</settlement><region type="region">État d'Oyo</region></placeName></affiliation></author><author><name sortKey="Ademowo, George O" sort="Ademowo, George O" uniqKey="Ademowo G" first="George O" last="Ademowo">George O. Ademowo</name></author><author><name sortKey="Saka, Yisa" sort="Saka, Yisa" uniqKey="Saka Y" first="Yisa" last="Saka">Yisa Saka</name></author><author><name sortKey="Davies, Emmanuel" sort="Davies, Emmanuel" uniqKey="Davies E" first="Emmanuel" last="Davies">Emmanuel Davies</name></author><author><name sortKey="Okoronkwo, Chukwu" sort="Okoronkwo, Chukwu" uniqKey="Okoronkwo C" first="Chukwu" last="Okoronkwo">Chukwu Okoronkwo</name></author><author><name sortKey="Bockarie, Moses J" sort="Bockarie, Moses J" uniqKey="Bockarie M" first="Moses J" last="Bockarie">Moses J. Bockarie</name></author><author><name sortKey="Molyneux, David H" sort="Molyneux, David H" uniqKey="Molyneux D" first="David H" last="Molyneux">David H. Molyneux</name></author><author><name sortKey="Kelly Hope, Louise A" sort="Kelly Hope, Louise A" uniqKey="Kelly Hope L" first="Louise A" last="Kelly-Hope">Louise A. Kelly-Hope</name></author></analytic><series><title level="j">PLoS neglected tropical diseases</title><idno type="eISSN">1935-2735</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Elephantiasis, Filarial (drug therapy)</term><term>Elephantiasis, Filarial (epidemiology)</term><term>Elephantiasis, Filarial (prevention & control)</term><term>Epidemiological Monitoring</term><term>Humans</term><term>Nigeria (epidemiology)</term><term>Prevalence</term><term>Topography, Medical</term><term>Wuchereria bancrofti (isolation & purification)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Filariose lymphatique ()</term><term>Filariose lymphatique (traitement médicamenteux)</term><term>Filariose lymphatique (épidémiologie)</term><term>Humains</term><term>Nigeria (épidémiologie)</term><term>Prévalence</term><term>Topographie médicale</term><term>Wuchereria bancrofti (isolement et purification)</term><term>Épidémiosurveillance</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Nigeria</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Wuchereria bancrofti</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Wuchereria bancrofti</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Filariose lymphatique</term><term>Nigeria</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Epidemiological Monitoring</term><term>Humans</term><term>Prevalence</term><term>Topography, Medical</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Filariose lymphatique</term><term>Humains</term><term>Prévalence</term><term>Topographie médicale</term><term>Épidémiosurveillance</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Nigeria</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Nigeria has a significant burden of lymphatic filariasis (LF) caused by the parasite Wuchereria bancrofti. A major concern to the expansion of the LF elimination programme is the risk of serious adverse events (SAEs) associated with the use of ivermectin in areas co-endemic with Loa filariasis. To better understand this, as well as other factors that may impact on LF elimination, we used Micro-stratification Overlap Mapping (MOM) to highlight the distribution and potential impact of multiple disease interventions that geographically coincide in LF endemic areas and which will impact on LF and vice versa.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24040432</PMID><DateCreated><Year>2013</Year><Month>09</Month><Day>16</Day></DateCreated><DateCompleted><Year>2014</Year><Month>03</Month><Day>12</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1935-2735</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>9</Issue><PubDate><Year>2013</Year></PubDate></JournalIssue><Title>PLoS neglected tropical diseases</Title><ISOAbbreviation>PLoS Negl Trop Dis</ISOAbbreviation></Journal><ArticleTitle>Lymphatic filariasis in Nigeria; micro-stratification overlap mapping (MOM) as a prerequisite for cost-effective resource utilization in control and surveillance.</ArticleTitle><Pagination><MedlinePgn>e2416</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pntd.0002416</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Nigeria has a significant burden of lymphatic filariasis (LF) caused by the parasite Wuchereria bancrofti. A major concern to the expansion of the LF elimination programme is the risk of serious adverse events (SAEs) associated with the use of ivermectin in areas co-endemic with Loa filariasis. To better understand this, as well as other factors that may impact on LF elimination, we used Micro-stratification Overlap Mapping (MOM) to highlight the distribution and potential impact of multiple disease interventions that geographically coincide in LF endemic areas and which will impact on LF and vice versa.</AbstractText><AbstractText Label="METHODOLOGY/PRINCIPAL FINDINGS" NlmCategory="RESULTS">LF data from the literature and Federal Ministry of Health (FMoH) were collated into a database. LF prevalence distributions; predicted prevalence of loiasis; ongoing onchocerciasis community-directed treatment with ivermectin (CDTi); and long-lasting insecticidal mosquito net (LLIN) distributions for malaria were incorporated into overlay maps using geographical information system (GIS) software. LF was prevalent across most regions of the country. The mean prevalence determined by circulating filarial antigen (CFA) was 14.0% (n = 134 locations), and by microfilaria (Mf) was 8.2% (n = 162 locations). Overall, LF endemic areas geographically coincided with CDTi priority areas, however, LLIN coverage was generally low (<50%) in areas where LF prevalence was high or co-endemic with L. loa.</AbstractText><AbstractText Label="CONCLUSIONS/SIGNIFICANCE" NlmCategory="CONCLUSIONS">The extensive database and series of maps produced in this study provide an important overview for the LF Programme and will assist to maximize existing interventions, ensuring cost effective use of resources as the programme scales up. Such information is a prerequisite for the LF programme, and will allow for other factors to be included into planning, as well as monitoring and evaluation activities given the broad spectrum impact of the drugs used.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Okorie</LastName><ForeName>Patricia N</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ademowo</LastName><ForeName>George O</ForeName><Initials>GO</Initials></Author><Author ValidYN="Y"><LastName>Saka</LastName><ForeName>Yisa</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Davies</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Okoronkwo</LastName><ForeName>Chukwu</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Bockarie</LastName><ForeName>Moses J</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><LastName>Molyneux</LastName><ForeName>David H</ForeName><Initials>DH</Initials></Author><Author ValidYN="Y"><LastName>Kelly-Hope</LastName><ForeName>Louise A</ForeName><Initials>LA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>09</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Negl Trop Dis</MedlineTA><NlmUniqueID>101291488</NlmUniqueID><ISSNLinking>1935-2727</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Bull World Health Organ. 2010 Jul 1;88(7):509-18</RefSource><PMID Version="1">20616970</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parasit Vectors. 2012;5:203</RefSource><PMID Version="1">22992226</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2011 Oct;5(10):e1346</RefSource><PMID Version="1">22022627</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Wkly Epidemiol Rec. 2012 Sep 14;87(37):346-56</RefSource><PMID Version="1">22977953</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2009 May;80(5):691-8</RefSource><PMID Version="1">19407107</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Angew Parasitol. 1992 Aug;33(3):125-31</RefSource><PMID Version="1">1416217</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Trop Med Parasitol. 2006 Dec;100(8):715-31</RefSource><PMID Version="1">17227650</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Vet Entomol. 1998 Jan;12(1):52-9</RefSource><PMID Version="1">9513939</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Trop Med Parasitol. 2006 Mar;100(2):163-72</RefSource><PMID Version="1">16492364</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Trop Med Parasitol. 2002 Dec;96 Suppl 2:S91-5</RefSource><PMID Version="1">12625922</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Agric Environ Med. 2005;12(2):181-6</RefSource><PMID Version="1">16457471</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2013;7(1):e2032</RefSource><PMID Version="1">23383355</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Trop Med Parasitol. 2003 Dec;97(8):827-38</RefSource><PMID Version="1">14754495</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parasit Vectors. 2012;5:53</RefSource><PMID Version="1">22433114</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Indian J Med Res. 1982 Oct;76:534-44</RefSource><PMID Version="1">6759378</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parasit Vectors. 2009 Aug 27;2(1):39</RefSource><PMID Version="1">19712455</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Parasitol. 1994 Jun;35(2):133-40</RefSource><PMID Version="1">8087153</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Infect Dis. 2013 Jan;13(1):89-94</RefSource><PMID Version="1">23084831</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 2005 Oct;10(10):1002-4</RefSource><PMID Version="1">16185234</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2012;6(7):e1600</RefSource><PMID Version="1">22860138</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2011;6(12):e28347</RefSource><PMID Version="1">22162764</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Trop Med Parasitol. 1988 Feb;82(1):75-82</RefSource><PMID Version="1">3041931</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Parasitol. 2012 Jun;28(6):231-8</RefSource><PMID Version="1">22503153</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Folia Parasitol (Praha). 1988;35(2):147-55</RefSource><PMID Version="1">3049274</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Trop Med Hyg. 1959 Jun;62(6):129-34</RefSource><PMID Version="1">13665767</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2006 Oct;75(4):650-5</RefSource><PMID Version="1">17038688</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Afr J Med Med Sci. 2010 Dec;39 Suppl:179-83</RefSource><PMID Version="1">22416661</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parasit Vectors. 2012;5:28</RefSource><PMID Version="1">22313631</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2008 Jan;78(1):153-8</RefSource><PMID Version="1">18187799</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parasitol Int. 2003 Mar;52(1):13-20</RefSource><PMID Version="1">12543143</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Trop. 1988 Jun;45(2):171-9</RefSource><PMID Version="1">2901204</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parasit Vectors. 2010 Oct 20;3:100</RefSource><PMID Version="1">20961435</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Afr J Infect Dis. 2011;5(2):47-53</RefSource><PMID Version="1">23878707</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parasit Vectors. 2011;4:178</RefSource><PMID Version="1">21923949</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2012 Aug;87(2):272-80</RefSource><PMID Version="1">22855758</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2009 Jan 24;373(9660):296-7</RefSource><PMID Version="1">19167564</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Microbiol Infect. 2011 Jul;17(7):977-85</RefSource><PMID Version="1">21722251</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 1997 Jul 5;350(9070):18-22</RefSource><PMID Version="1">9217715</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Trop. 1990 Dec;48(2):137-47</RefSource><PMID Version="1">1980569</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Malar J. 2008;7:145</RefSource><PMID Version="1">18667077</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Vector Borne Dis. 2011 Jun;48(2):78-84</RefSource><PMID Version="1">21715729</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2011 Jun;5(6):e1210</RefSource><PMID Version="1">21738809</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Infect Genet Evol. 2010 Mar;10(2):159-77</RefSource><PMID Version="1">19941975</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Trop Med Parasitol. 1986 Aug;80(4):425-32</RefSource><PMID Version="1">3539045</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2003 Jun;68(6):643-6</RefSource><PMID Version="1">12887020</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parasit Vectors. 2013;6:39</RefSource><PMID Version="1">23433078</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Vector Borne Dis. 2010 Jun;47(2):91-6</RefSource><PMID Version="1">20539046</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Vector Borne Dis. 2011 Dec;48(4):197-204</RefSource><PMID Version="1">22297280</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Trop Med Parasitol. 2002 Dec;96 Suppl 2:S129-32</RefSource><PMID Version="1">12630402</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Wkly Epidemiol Rec. 2011 Mar 25;86(13):121-7</RefSource><PMID Version="1">21438441</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 2004 May 8;328(7448):1129-32</RefSource><PMID Version="1">15130985</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062665" MajorTopicYN="N">Epidemiological Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009549" MajorTopicYN="N" Type="Geographic">Nigeria</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019371" MajorTopicYN="Y">Topography, Medical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014958" MajorTopicYN="N">Wuchereria bancrofti</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC3764235</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>02</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>07</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24040432</ArticleId><ArticleId IdType="doi">10.1371/journal.pntd.0002416</ArticleId><ArticleId IdType="pii">PNTD-D-13-00176</ArticleId><ArticleId IdType="pmc">PMC3764235</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Nigeria</li></country><region><li>État d'Oyo</li></region><settlement><li>Ibadan</li></settlement><orgName><li>Université d'Ibadan</li></orgName></list><tree><noCountry><name sortKey="Ademowo, George O" sort="Ademowo, George O" uniqKey="Ademowo G" first="George O" last="Ademowo">George O. Ademowo</name><name sortKey="Bockarie, Moses J" sort="Bockarie, Moses J" uniqKey="Bockarie M" first="Moses J" last="Bockarie">Moses J. Bockarie</name><name sortKey="Davies, Emmanuel" sort="Davies, Emmanuel" uniqKey="Davies E" first="Emmanuel" last="Davies">Emmanuel Davies</name><name sortKey="Kelly Hope, Louise A" sort="Kelly Hope, Louise A" uniqKey="Kelly Hope L" first="Louise A" last="Kelly-Hope">Louise A. Kelly-Hope</name><name sortKey="Molyneux, David H" sort="Molyneux, David H" uniqKey="Molyneux D" first="David H" last="Molyneux">David H. Molyneux</name><name sortKey="Okoronkwo, Chukwu" sort="Okoronkwo, Chukwu" uniqKey="Okoronkwo C" first="Chukwu" last="Okoronkwo">Chukwu Okoronkwo</name><name sortKey="Saka, Yisa" sort="Saka, Yisa" uniqKey="Saka Y" first="Yisa" last="Saka">Yisa Saka</name></noCountry><country name="Nigeria"><region name="État d'Oyo"><name sortKey="Okorie, Patricia N" sort="Okorie, Patricia N" uniqKey="Okorie P" first="Patricia N" last="Okorie">Patricia N. Okorie</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001A47 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001A47 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:24040432
|texte= Lymphatic filariasis in Nigeria; micro-stratification overlap mapping (MOM) as a prerequisite for cost-effective resource utilization in control and surveillance.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:24040432" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |